secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zeo ScientifiX, Inc. (ZEOX)
CIK:        0001557376
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001829126-25-004668
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZEO launches physician masterclass ahead of Florida's SB-1768 stem cell therapy law
--------------------------------------------------------------------------------

- Florida's SB-1768, effective July 1, 2025, permits MDs and DOs to offer non-FDA-approved stem cell therapies under strict compliance.
- ZEO's Masterclass on June 27, 2025, at NOVA Southeastern University educates physicians on SB-1768 compliance and clinical integration.
- Company positions itself as trusted supplier of compliant stem cell products via its FDA-registered facility.
- No financial guidance, revenue impact, or clinical trial results included in the announcement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557376/000182912625004668/0001829126-25-004668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557376/000182912625004668/zeoscientifix_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-004668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer